NEWS RELEASE: Appili Submits Protocol for a Phase 3 Study Evaluating Favipiravir for the Treatment of Patients with COVID-19 Infections to the US FDA

by Shana Cristoferi | Sep 15, 2020 | Appili Therapeutics, News

Read original News Release  HALIFAX, Nova Scotia, September 11, 2020 – Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today announced that it has submitted a new...

NEWS RELEASE: Health and life sciences companies focused on mental health and wellness invited to pitch at second Health Challenge event

by Shana Cristoferi | Aug 30, 2020 | News

Health and life sciences companies focused on mental health and wellness invited to pitch at second Health Challenge event HALIFAX, NS – August 30, 2020 – Health and life sciences companies in Atlantic Canada are being invited to present their innovative...

NEWS RELEASE: Eastern Ontario Regional Laboratory Association (EORLA) and Roche Diagnostics join forces for seroprevalence study for SARS-CoV-2

by Shana Cristoferi | Aug 4, 2020 | News, Roche

EORLA to use Elecsys® Anti-SARS-CoV-2 antibody test that helps determine exposition to the virus and development of antibodies Read Orginal Here OTTAWA, ON, Aug. 4, 2020 /CNW Telbec/ – Roche Diagnostics, a division of Hoffmann-La Roche Limited, and the Eastern...

Novagevity to Develop Canada’s First Plant-Based Meal Replacement Beverage, Receives $300k from ACOA

by Shana Cristoferi | Jul 21, 2020 | News, Novagevity

Tuesday, July 21, 2020 – Halifax, Nova Scotia — Novagevity Incorporated will receive $300,000 from the Atlantic Canada Opportunities Agency (ACOA) to accelerate their launch of plant nutrition products to optimize human health, nutrition, and recovery. The...

IMV CEO interviewed by CTV: Canadian lab races for COVID-19 vaccine

by Shana Cristoferi | Jul 16, 2020 | IMV Inc., News

Watch here IMV’s CEO, Frederic Ors, was interviewed by CTV Montreal, providing more details about the IMV’s COVID-19 vaccine candidate and unique delivery platform, DPX.